The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD.

scientific article

The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1033593424
P356DOI10.1186/1471-2466-10-55
P932PMC publication ID2987952
P698PubMed publication ID21054892
P5875ResearchGate publication ID47698885

P2093author name stringJean Bourbeau
François Maltais
Sarah Bernard
Louis Laviolette
Francesco Sava
Marie-Josée Breton
P2860cites workEffects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trialQ46606771
The effect of obesity on disability vs mortality in older AmericansQ46945908
The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patientsQ47206206
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseQ47286648
Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyQ47665346
Pulmonary rehabilitation and the BODE index in COPD.Q47716426
Body composition and mortality in chronic obstructive pulmonary diseaseQ47767873
The impact of obesity on health-related quality-of-life in the general adult US population.Q51931288
Ground walk training improves functional exercise capacity more than cycle training in people with chronic obstructive pulmonary disease (COPD): a randomised trial.Q53075749
Assessing the impact of pulmonary rehabilitation on functional status in COPD.Q53174821
Aerobic and strength training in patients with chronic obstructive pulmonary disease.Q53557424
Quality of life in relation to overweight and body fat distribution.Q53565128
Comprehensive pulmonary rehabilitation according to severity of COPD.Q54183145
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.Q55067747
The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.Q55485607
Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample: Findings from the Copenhagen City Heart StudyQ57955931
Efficacy of standard rehabilitation in COPD outpatients with comorbiditiesQ58877060
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitationQ58877133
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary DiseaseQ61875242
COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary careQ63248202
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory QuestionnaireQ68139804
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trialQ71723693
Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjectsQ72147584
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patientsQ73227901
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary diseaseQ73509656
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary diseaseQ74287088
Obesity is a risk factor for dyspnea but not for airflow obstructionQ74387204
St. George's Respiratory Questionnaire: MCIDQ79395290
Ventilatory and perceptual responses to cycle exercise in obese womenQ79599027
Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise toleranceQ84865931
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseQ22299313
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of HealthQ28288766
Standardisation of spirometryQ29547365
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyQ29616361
Effect of obesity on constant workrate exercise in hyperinflated men with COPD.Q30983956
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review.Q34008788
ATS StatementQ34136219
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseQ34546085
Nutritional and metabolic modulation in chronic obstructive pulmonary disease managementQ35585633
Body composition and functional limitation in COPD.Q35633624
Effect of encouragement on walking test performanceQ36140930
Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog ScaleQ36669434
The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD.Q37333393
Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.Q37340174
Effects of obesity and fat distribution on ventilatory function: the normative aging study.Q40899892
Adverse effect of additional weight on exercise against gravity in patients with chronic obstructive airways diseaseQ41136025
French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary diseaseQ43524404
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseQ44067405
Work capacity and cardiopulmonary adaptation of the obese subject during exercise testingQ44439419
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyQ46568144
P921main subjectchronic obstructive pulmonary diseaseQ199804
obesityQ12174
P304page(s)55
P577publication date2010-11-06
P1433published inBMC Pulmonary MedicineQ15755469
P1476titleThe impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD.
P478volume10

Reverse relations

cites work (P2860)
Q39574667Assessment of nutritional status and meal-related situations among patients with chronic obstructive pulmonary disease in Primary health care - obese patients; a challenge for the future
Q35805903Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease
Q38036786COPD and associated comorbidities: a review of current diagnosis and treatment
Q37941499COPD and the metabolic syndrome: an intriguing association.
Q35312449Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers
Q50500889Does body mass index influence the outcomes of a Waking-based pulmonary rehabilitation programme in COPD?
Q58563190Ectopic adiposity and cardiometabolic health in COPD
Q42323707Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
Q34345626Effects of body mass index on task-related oxygen uptake and dyspnea during activities of daily life in COPD
Q37986234Impact of obesity on exercise performance and pulmonary rehabilitation.
Q27026426Influence of diet and obesity on COPD development and outcomes
Q34529777Management of chronic obstructive pulmonary disease beyond the lungs
Q95641902Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
Q37109180Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD).
Q35648257Obesity and extent of emphysema depicted at CT.
Q83552780Obesity and physical activity in the daily life of patients with COPD
Q47359885Obesity in COPD: Revealed and Unrevealed Issues
Q34344150Obesity in chronic obstructive pulmonary disease: is fatter really better?
Q27011554Pathogenesis of hyperinflation in chronic obstructive pulmonary disease
Q36161117Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease
Q47638603Results of a Multimodal Program During Hospitalization in Obese COPD Exacerbated Patients.
Q38081828Should all patients with COPD be exercise trained?
Q33952700Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care
Q38178935The association between co-morbidities and physical performance in people with chronic obstructive pulmonary disease: a systematic review
Q41866097The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: a systematic review
Q34425486The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study
Q38195651When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences